• Jingyi Jessica Li, PhD (University of California, Los Angeles)
  The junction of statistics and biology

• Eric J. Wagner, PhD (University of Texas Medical Branch at Galveston)
  Alternative Polyadenylation in cancers and brain disorders

• Albert La Spada, MD, PhD, FACMGG (University of California Irvine School of Medicine)
  Alternative Polyadenylation in Amyotrophic Lateral Sclerosis (ALS)

• Qianben Wang, PhD (School of Medicine, Duke University)
  Alternative Polyadenylation in Prostate Cancer

• Lanlan Shen, MD (Baylor College of Medicine)
  DNA methylation in stem cells and aging

• Or Gozani, PhD (Department of Biology, Stanford University)
  Mechanisms of histone methyltransfersase

• Katrin F. Chua, MD, PhD (Department of Medicine, Stanford University)
  Epigenetic regulation of mammalian SIRT factors

• Xiaobing Shi, PhD (Van Andel Research Institute)
  Readers of histone posttranslational modifications

• Peggy Goodell, PhD (Stem Cells and Regenerative Medicine, Baylor College of Medicine)
  DNA methylation in normal and malignant hematopoiesis

• Huda Y. Zoghbi, MD (Howard Hughes Medical Institute, Baylor College of Medicine)
  Epigenetic and transcription regulation in neural development and diseases

• Sharon Y. Dent, PhD (Center for Cancer Epigenetics, M. D. Anderson Cancer Center)
  Nucleosome remodeling

• Jean-Pierre Issa (President and Chief Executive Officer of the Coriell Institute for Medical Research)
  DNA Hypermethylation in Cancer

• Steven P. Balk, MD, PhD (Beth Israel Deaconess Medical Center, Harvard Medical School)
  Prostate Cancer RNA-seq